MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada.
Division of Neurosurgery, Department of Surgery, The University of Toronto, Toronto, ON, Canada.
Adv Exp Med Biol. 2023;1416:159-173. doi: 10.1007/978-3-031-29750-2_12.
While the majority of meningiomas encountered clinically are sporadic, there is a rare subset that arises due to early life or childhood irradiation. Sources of this radiation exposure may be due to treatment of other cancers such as acute childhood leukemia, other central nervous system tumors such as medulloblastoma, the treatment of tinea capitis (rarely and historically), or environmental exposures, as seen in some of the Hiroshima and Nagasaki atomic bomb survivors. Regardless of their etiology, however, radiation-induced meningiomas (RIMs) tend to be highly biologically aggressive irrespective of WHO grade and are usually refractory to the conventional treatment modalities of surgery and/or radiotherapy. In this chapter, we will discuss these RIMs in their historical context, their clinical presentation, their genomic features and ongoing efforts to better understand these tumors from a biological standpoint in order to develop better, more efficacious therapies for these patients.
虽然临床上遇到的大多数脑膜瘤是散发性的,但有一小部分是由于早年或儿童时期的辐射引起的。这些辐射暴露的来源可能是由于治疗其他癌症,如急性儿童白血病,其他中枢神经系统肿瘤,如髓母细胞瘤,头癣的治疗(很少见,历史上),或环境暴露,如在一些广岛和长崎原子弹幸存者中看到的那样。然而,无论其病因如何,辐射诱导的脑膜瘤(RIM)往往具有高度的生物学侵袭性,与世界卫生组织(WHO)分级无关,并且通常对手术和/或放射治疗的常规治疗方法有抗性。在这一章中,我们将在历史背景下讨论这些 RIM,包括它们的临床表现、基因组特征以及为了从生物学角度更好地理解这些肿瘤而正在进行的努力,以便为这些患者开发更好、更有效的治疗方法。